A carbohydrate-linked cisplatin analogue having antitumor activity

Angewandte Chemie - International Edition

Volumn 38, Issue 12, 1999, Pages 1768-1769

  Chen, Yongsheng ^a   Heeg, Mary J ^a   Braunschweiger, Paul G ^b   Xie, Wenhua ^a   Wang, Peng G ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antitumor agents; Bioinorganic chemistry; Carbohydrates; N ligands; Platinum

Indexed keywords

CARBOHYDRATE; CISPLATIN DERIVATIVE; DICHLORO[(2 BETA DEXTRO GLUCOPYRANOSIDYL)PROPANE 1,3 DIAMINE]PLATINUM; METAL COMPLEX; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CARBOHYDRATE ANALYSIS; CHEMICAL STRUCTURE; CRYSTAL; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; SOLUBILITY;

EID: 0033553803     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1768::AID-ANIE1768>3.0.CO;2-6     Document Type: Article

References (25)

1. B. Rosenberg, L. VanCamp, J. E. Trosko, V. H. Mansour, Nature (London) 1969, 222, 385-386.
2. a) Metal Complexes in Cancer Chemotherapy (Ed.: B. K. Keppler), VCH, Weinheim, 1993;
3. b) Molecular Aspects of Anticancer Drug - DNA Interactions, Vol. 1 (Eds.: S. Neidle, M. Waring), Macmillian, Basingstoke, 1993;
4. c) J. Reedijk, Chem. Commun. 1996, 801-806.
5. Reviews: a) A. Pasini; F. Zunino, Angew. Chem. 1987, 99, 632-642;
6. Angew. Chem. Int. Ed. Engl. 1987, 26, 615-624;
7. b) R. B. Weiss, M. C. Christian, Drugs 1993, 46, 360-377.
8. a) J. Reedijk, Inorg. Chim. Acta 1992, 198-200, 873-881, and references therein;
9. b) A. Iakovidis, N. Hadjiliadis, Coord. Chem. Rev. 1994, 135/ 136, 17-63, and references therein;
10. c) K. F. Morris, L. E. Erickson, B. V. Panajotova, D. W. Jiang, F. Ding, Inorg. Chem. 1997, 36, 601-607.
11. a) S. Hakamori, Annu. Rev. Biochem. 1981, 50, 733-764;
12. b) Y.-T. Li, S.-C. Li, Adv. Carbohydr. Chem. Biochem. 1982, 40, 235.
13. For examples of platinum(II) complexes of diamino-dideoxy carbohydrates (coordination through the amino groups) as cisplatin analogues, see a) T. Tsubomura, M. Ogawa, S. Yano, K. Kobayashi, T. Sakurai, S. Yoshikawa, Inorg. Chem. 1990, 29, 2622-2626;
14. b) S. Hanessian, J. Y. Gauthier, K. Okamoto, A. L. Beauchamp, T. Theophanides, Can. J. Chem. 1993, 71, 880-885;
15. c) S. Hanessian, J.-G. Wang, Can. J. Chem. 1993, 71, 886-895.
16. 3 in DMF.
17. 2).
18. -3. The structure was solved and refined with the programs SHELXS-93 and SHELXTL. The hydrogen atoms were placed in their geometric positions (riding model), except that no hydrogen atoms were placed in the solvent molecules. Crystallographic data (excluding structure factors) for the structure reported in this paper have been deposited with the Cambridge Crystallographic Data Center as supplementary publication no. CCDC-113805. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB21EZ, UK (fax: (+44) 1223-336-033; e-mail: deposit@ccdc.cam.ac.uk).
19. For examples, see reference [6].
20. J. Wang, Y. L. Bennani, F. Belanger-Gariepy, S. Hanessian, Acta Crystallogr. Sect. C 1991, 47, 1067-1069, and references therein; see also reference [6].
21. P. G. Braunschweiger, V. S. Basrur, O. Santos, J. P. Perras, A. M. Markoe, P. Houdek, J. G. Schwade, Biotherapy 1997, 10, 129-137.
22. -1 at 25°C.
23. Crystal structures of platinum(II) complexes of unprotected carbohydrate diolates have been reported, but there the carbohydrates are directly bound to platinum, and the complexes are not used in biological study. For examples, see a) A. Appelt, A. C. Willis, S. B. Wild, J. Chem. Soc. Chem. Commun. 1988, 938-940;
24. b) M. A. Andrews, G. L. Gould, Organometallics 1991, 10, 387-389;
25. c) M. A. Andrews, E. J. Voss, G. L. Gould, W. T. Klooster, T. F. Koetzle, J. Am. Chem. Soc. 1994, 116, 5730-5740.